I’ve written before about the limits and opportunities of health
information technology. HIT, as it’s more commonly known, is just that
– health information technology. It can be an important and useful
tool. But it is the user of that technology – the clinician, the
pharmacist, the administrator, the analyst – who ultimately determines
its value. If the user invests in it – financially, psychologically
and intellectually – then great things can happen. Otherwise, it’s
just a tool. Nothing more.
So when people start talking about spending $25-50 billion on HIT as
part of an economic stimulus bill, I get a little uncomfortable. $50
billion would be twice the size of the annual NIH budget – a very big
number. Are we sure the funding – and whatever technology comes of it
– will be incorporated in a way that maximizes its use and value, or
not?
By